Q3 2012: The Jean Coutu Group’s results remained at the upper end of expectations in Q3 2012 with net earnings up 5.9% to $51.7 million. EPS rose to $0.23 from $0.21 in the quarter and to $0.64 (pre unusual) from $0.58 for the 39 weeks ended November 26, 2011. The earnings growth primarily reflected improved operating performance in its core distribution business and was achieved despite lower prices for generic drugs.
Please contact your Investment Advisor for more information on this research.